These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8623382)

  • 21. Porcine heart xenograft function and hyperacute rejection: the role of thrombin inhibition.
    Uchita S; Thein E; Huber H; Wimmer C; Kur F; Brenner P; Hammer C
    Transplant Proc; 2001; 33(1-2):729-31. PubMed ID: 11267043
    [No Abstract]   [Full Text] [Related]  

  • 22. Xenogeneic orthotopic liver transplantation from sheep to pig: delay of rejection by FUT 175 Infusion.
    Gridelli B; Gatti S; Andreani P; Donato MF; Bergamaschini L; Berti E; Di Mauro P; Maggioni L; Orsenigo R; Fassati LR; Galmarini D
    Transplant Proc; 1996 Apr; 28(2):784-7. PubMed ID: 8623399
    [No Abstract]   [Full Text] [Related]  

  • 23. White blood cells and platelets are integral to the hyperacute rejection of the pig heart by human blood.
    Young VK; Kaspar-König W; Tew DN; Wallwork J; White DJ; Pierson RN
    Transplant Proc; 1995 Feb; 27(1):272-3. PubMed ID: 7879000
    [No Abstract]   [Full Text] [Related]  

  • 24. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.
    Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Xenotransplantation; 2007 Jan; 14(1):34-47. PubMed ID: 17214703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival.
    Davis EA; Lam TT; Qian Z; Ibrahim S; Baldwin WM; Sanfilippo FP
    J Heart Lung Transplant; 1995; 14(5):973-80. PubMed ID: 8800736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism.
    Tanaka M; Latinne D; Gianello P; Sablinski T; Lorf T; Bailin M; Nickeleit V; Colvin R; Lebowitz E; Sykes M
    Transplant Proc; 1994 Jun; 26(3):1326-7. PubMed ID: 8029926
    [No Abstract]   [Full Text] [Related]  

  • 27. Spectrum of vascular pathologic changes in primate cardiac xenografts.
    McManus RP; O'Hair DP; Hunter JB; Komorowski R
    Transplant Proc; 1992 Apr; 24(2):619-24. PubMed ID: 1566454
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
    Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
    Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model.
    Kobayashi T; Neethling FA; Koren E; Taniguchi S; Ye Y; Niekrasz M; Takagi H; Hancock WW; Cooper DK
    Transplant Proc; 1996 Apr; 28(2):604. PubMed ID: 8623297
    [No Abstract]   [Full Text] [Related]  

  • 30. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection.
    Rose AG; Cooper DK
    J Heart Lung Transplant; 1996 Aug; 15(8):804-17. PubMed ID: 8878763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of complement suppression on xenograft survival in hyperacute rejection.
    Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
    Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of MX-1 on survival of discordant cardiac xenografts from guinea pig to rat.
    Kaji H; Platt JL; Sutherland DE; Inoue K; Mori C; Shiota K; Imamura M
    Transpl Immunol; 1997 Mar; 5(1):70-2. PubMed ID: 9106338
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and anti-Gal column immunoadsorption.
    Zhang JP; Blum MG; Chang AC; Shyr Y; Blair KS; Awwad M; Pierson RN
    Xenotransplantation; 1999 Nov; 6(4):249-61. PubMed ID: 10704068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy.
    Fujiwara I; Nakajima H; Arakawa K; Akioka K; Takeshita K; Oka T
    Transplant Proc; 1996 Apr; 28(2):685-6. PubMed ID: 8623345
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection.
    Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
    Transplantation; 1991 Nov; 52(5):868-73. PubMed ID: 1949173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonmuscle myosin heavy chain and nuclear factor-kappa B expression in pig-to-primate xenotransplanted hearts.
    Takayama K; Suzuki J; Kawauchi M; Tsukioka K; Wada Y; Zhang T; Endoh M; Takamoto S; Amano J; Isobe M
    Transplant Proc; 2000 Aug; 32(5):1092-4. PubMed ID: 10936372
    [No Abstract]   [Full Text] [Related]  

  • 38. Absence of hyperacute rejection and preservation of function in HDAF transgenic pig kidneys exposed to prolonged cold ischaemia.
    Masroor S; Cozzi E; Soin B; Vial C; Chavez G; Smith KG; Bradley JR; White DJ; Friend PJ
    Transplant Proc; 2000 Aug; 32(5):965-6. PubMed ID: 10936300
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolonged cardiac xenograft survival in guinea pig-to-rat model by a highly active cobra venom factor.
    Sun QY; Chen G; Guo H; Chen S; Wang WY; Xiong YL
    Toxicon; 2003 Sep; 42(3):257-62. PubMed ID: 14559076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival.
    Stevens RB; Wang YL; Kaji H; Lloveras J; Dalmasso A; Bach FH; Rubinstein P; Sutherland DE; Platt JL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):382. PubMed ID: 8438344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.